Monocyte [cell]
suppressing [ftcn]
Effect [qlco]
Bezafibrate [orch, phsu]
Not [ftcn]
Patients [podg]
Isolated [ftcn]
Hypertriglyceridaemia [fndg]
Fibrates [orch, phsu]
treatment [ftcn]
Increased [qnco]
Triglyceride level [lbtr]
effects [qlco]
Agent [chvf]
Patients [podg]
Isolated [ftcn]
Hypertriglyceridaemia [fndg]
Poorly [qlco]
Understand [menp]
Aim [idcn]
Study [mnob]
To [qlco]
Compare [acty]
Effect [qlco]
Bezafibrate [orch, phsu]
Monocyte [cell]
cytokine [aapp, imft]
Release [hlca]
Systemic [ftcn]
Inflammation [patf]
Type [qlco]
Dyslipidaemia [dsyn]
Study Subject [grup]
included [ftcn]
Seven [qnco]
One [qnco]
Three [qnco]
Group [idcn]
treated [topp]
mg% [qnco]
Twice daily [tmco]
g% [qnco]
Twice daily [tmco]
placebo [topp]
days [tmco]
Three [qnco]
Subject [grup]
COMPLETED [qlco]
Study [mnob]
Improvement [cnce]
Lipid [lipd]
Profile [lbpr]
Bezafibrate [orch, phsu]
treatment [ftcn]
Reduced [qlco]
Plasma C-reactive protein level [lbpr]
High sensitivity [lbpr]
inhibited [qlco]
Monocyte [cell]
Release [hlca]
tumor necrosis factor-alpha [aapp, imft]
Bezafibrate [orch, phsu]
Action [ftcn]
Plasma C-reactive protein [aapp]
High sensitivity [lbpr]
Monocyte [cell]
cytokine [aapp, imft]
Release [hlca]
Lipid [lipd]
Independent [idcn]
Correlated [qlco]
Drug-induced [ftcn]
Improvement [cnce]
Insulin Sensitivity [patf]
Reduced [qlco]
Plasma [bdsu]
Triglycerides [bacs, lipd]
Not [ftcn]
Induce [ftcn]
Monocyte [cell]
Secretory [celf]
function [phsf]
Plasma C-reactive protein [aapp]
High sensitivity [lbpr]
Study [mnob]
Suggest [idcn]
Bezafibrate [orch, phsu]
Superior [spco]
Reducing [qlco]
Systemic [ftcn]
Inflammation [patf]
Monocyte [cell]
suppressing [ftcn]
effects [qlco]
Anti-inflammatory [phsu]
Action [ftcn]
Bezafibrate [orch, phsu]
Contribute [acty]
Clinical [qlco]
Effectiveness [qlco]
Fibrates [orch, phsu]
Prevention [topp]
treatment [ftcn]
Isolated [ftcn]
Hypertriglyceridaemia [fndg]
